Joint Heads of Medicines Agencies (HMA)/European Medicines Agency (EMA) multistakeholder workshop on Patient Registries for Alzheimer's disease, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 15 December 2025, 09:00 (CET) to 15 December 2025, 17:30 (CET)

Published 18 hours ago• 1 minute read

This joint hybrid HMA/EMA Patient Registries workshop aims to facilitate the long-term follow up of medicines for Alzheimer's Disease (AD), and enable the generation of meaningful safety and efficacy/effectiveness data using existing patient registries.

The event will bring together representatives of registry holders, regulatory agencies, pharmaceutical companies, patients, healthcare professionals, academia, and health technology assessment bodies to address the following objectives:

Origin: